Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
67,195.84 +1,389.31 (+2.11%) CMC Crypto 200
1,373.84 -0.01 (-0.00%)
Panacea Life Sciences Holdings, Inc. (PLSH)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 10:13AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.44M |
| Enterprise value | 24.18M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.85 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 8.75 |
| Enterprise value/EBITDA | -2.95 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -73.38% |
| S&P500 52-week change 3 | 26.36% |
| 52-week high 3 | 0.5799 |
| 52-week low 3 | 0.0960 |
| 50-day moving average 3 | 0.1683 |
| 200-day moving average 3 | 0.1900 |
Share statistics
| Avg vol (3-month) 3 | 5.45k |
| Avg vol (10-day) 3 | 3.41k |
| Shares outstanding 5 | 17.65M |
| Implied shares outstanding 6 | 17.65M |
| Float 8 | 217.57k |
| % held by insiders 1 | 57.41% |
| % held by institutions 1 | 0.00% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 11 Mar 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -277.51% |
| Operating margin (ttm) | -100.08% |
Management effectiveness
| Return on assets (ttm) | -18.47% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 2.76M |
| Revenue per share (ttm) | 0.16 |
| Quarterly revenue growth (yoy) | 55.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -3.64M |
| Net income avi to common (ttm) | -7.67M |
| Diluted EPS (ttm) | -0.4500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 117.15k |
| Total cash per share (mrq) | 0.01 |
| Total debt (mrq) | 21.86M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.23 |
| Book value per share (mrq) | -0.53 |
Cash flow statement
| Operating cash flow (ttm) | -1.57M |
| Levered free cash flow (ttm) | -170.86k |
© 2024 Yahoo. All rights reserved.